Blog
T1International Statement on Walmart Insulin
1 Jun 2018, 9:34 a.m. in #insulin4all USA, News & Statements by T1International
Recently, the American Diabetes Association issued a white paper on Insulin Access and Affordability by their Working Group. While we continue to applaud the American Diabetes Association for speaking out about the high cost of insulin, we remain concerned with their approach and some of the recommendations in their paper.
Read more
Extreme Measures for Insulin
29 May 2018, 9:48 a.m. in #insulin4all USA by Hattie Saltzman
I carry a machine everywhere I go. Not a phone, or a tablet, or an iPod – it’s an insulin pump. It’s connected to my body with a tiny cannula that rests under my skin, pumping a fluid through 23” of tubing. I would die without it. Read more
A Type 1 Perspective from Siberia to Moscow
18 May 2018, 11:24 a.m. in Global Stories by Ksenia Sudorgina
Diabetes entered in my life when I was 7 years old It was my first year in school and at the time, I was living in a small town in the southwestern part of Eastern Siberia. I consider myself lucky: my mother is a doctor and for me the transition to my new life went quite smoothly. It is only now that I understand that our family avoided many dangerous myths. Read more
My Journey to Eli Lilly HQ for Answers
9 May 2018, 3:34 p.m. in #insulin4all USA, News & Statements by Nicole Smith-Holt
I was very nervous before going to confront the top executives of Eli Lilly and Company. But I was determined to tell them Alec’s story. They needed to hear from me what their insulin prices did to Alec, and are still doing to others. Read more
T1International Testimony for Insulin Access & Affordability: The Rising Cost of Treatment
8 May 2018, 10:25 a.m. in #insulin4all USA, News & Statements by T1International
T1International’s 2018 global survey explored out-of-pocket costs for people with type 1 diabetes. More than 25% of American respondents said that they have had to ration insulin at least once per year due to cost. Fourteen percent of those respondents have had to ration their insulin monthly, weekly, or daily due to insulin cost. Read more
Patient Activism is Seizing the Spotlight—And Rightly So
1 May 2018, 1:16 p.m. in #insulin4all USA, News & Statements by Fran Quigley
In today’s struggle on insulin pricing and other drugs, patient can win the day again. So our organization, People of Faith for Access to Medicines, is proud to be in support of T1International’s amazing work, from the Eli Lilly demonstration to the #insulin4all meetups in New York City and the Cincinnati area. Read more
No Blood Glucose Testing in Gaza
20 Apr 2018, 11:18 a.m. in Global Stories, Interviews by Elizabeth Pfiester
"We live in a dangerous area, so it's hard to be in a good mood. There are wars, so I always trying not to be scared when I hear bombs." – Deema, living with type 1 diabetes in Gaza Read more
Open letter to Elected Officials in America from #insulin4all Advocates
11 Apr 2018, 10:33 a.m. in by T1International
We live and vote in your states, and all of us have type 1 diabetes or love someone with the life-long, non-preventable autoimmune disease. We want to talk about the insulin pricing crisis, and we want you to make the issue part of your legislative priorities. Read more
World Health Day: Universal Health Coverage (#healthforall)
6 Apr 2018, 2:27 p.m. in News & Statements by Elizabeth Pfiester
Excitingly, the WHO has chosen to highlight Universal Health Coverage in 2018 by choosing it as the theme for World Health Day on April 7th. At T1International, we will use the day to continue to highlight the importance of Universal Health Coverage for people with type 1 diabetes. Read more
Advocates meet for #insulin4all in Cincinnati
3 Apr 2018, 5:13 p.m. in #insulin4all USA, News & Statements by Angela Lautner
“Access to insulin is a human right”: this was the central theme during a gathering of #insulin4all advocates in Cincinnati on March 25th. The group came together to focus on regional action in Kentucky, Ohio, and Indiana regarding insulin pricing. Advocate Angela Lautner shares her perspective. Read more